SCIENCE AND TECH
Hugo is the result of GHGSat's first collaboration with international leader in technology, ABB Measurement & Analytics Canada
GHGSat, the global leader in high-resolution greenhouse gas monitoring from space, has successfully completed the launch of its third satellite, GHGSat-C2 (“Hugo”), which launched aboard a SpaceX Falcon 9 from Cape Canaveral Space Force Station at 10:00 ET / 15:00 UTC on January 24th, 2021.
The satellite, brokered and integrated via Nanoracks, separated from Falcon 9, 68 min after liftoff. Hugo is expected to enter commercial service within a few weeks.
Hugo is the result of GHGSat’s first collaboration with ABB, the engineering firm which manufactured the payload. Previous GHGSat satellite launches include technology demonstrator “Claire” (or GHGSat-D), which has been in orbit since 2016, and “Iris” (GHGSat-C1), which launched September 2nd, 2020.
Hugo is the second of a fleet of 10 commercial, high-resolution satellites due to be in orbit by the end of 2022. Each satellite is equipped with a state-of-the-art sensor that detects methane emissions from sources 100 times smaller, at a resolution that is 100 times higher, than any other commercial or state-funded satellite. Iris has already detected and quantified smaller plumes than GHGSat-D (“Claire”) for industries such as oil & gas, waste management, and mining.
Stephane Germain, CEO of GHGSat: “Hugo’s successful launch doubles our commercial capacity in orbit for performing high-resolution measurements of facility-level emissions. This launch starts the year on a high note as the next step in deploying our constellation.”
Three more GHGSat satellites are currently being manufactured, and each will include patented GHGSat sensors manufactured under contract by ABB Measurement & Analytics Canada. Marc Corriveau, General Manager ABB Measurement & Analytics Canada said: “ABB is very pleased to support…
CURRENT EDITION
WEATHER
TODAY
RH
NEWSDESK
Charitable Nonprofits Send Letter to President Biden and Congressional Leaders Making Case for Pandemic Relief
On January 22, 75 national nonprofits sent a letter to President Biden and congressional leadership
Six Cities Share $745,000 in Grants Through the 2021 Childhood Obesity Prevention and Environmental Health and Sustainability Awards
The United States Conference of Mayors (USCM) and the American Beverage Foundation for a Healthy
Degenics.com Aims to Provide Anonymous Personal Genetic Testing Through a Decentralized Blockchain Platform
In January 2021, Degenics was launched as a blockchain-based, anonymous-first DNA testing platform, in collaboration with Blocksphere, a blockchain consulting company. Degenics intends to partner with projects in the Polkadot ecosystem, including KILT Protocol to incorporate credentials for the project’s genetic lab & genetic products…
The One Product Americans Will Need When They Return to Traveling
After months of staying at home, Americans are catching the travel bug.
There is pent-up demand to hit the road. Skift Research’s monthly travel tracker survey reveals about a third of the U.S. population will be packing their bags within three months after restrictions are lifted….
Stress-Induced Bruxism and What to Do About It
Chronic stress has become a part of our daily lives. Whether it’s from a work deadline, an upcoming school exam, filing taxes, or being cut off in traffic. And being stuck indoors during a pandemic hasn’t helped.
Did you know, however, that stress is not only a constant source of…
Former U.S. Director of National Intelligence Joins Emerging Tech Fest Keynote Event Line Up
James (Jim) Clapper, President Obama’s former Director of National Intelligence, will join Aled Miles, President & Chief Executive Officer, Sauce Labs, for an exclusive interview as part of the 2021 Emerging Tech Fest’s keynote event.
Taking place across 26th – 28th January as a virtual, global event, the 3-day festival…
NASA Conducts Test of SLS Rocket Core Stage for Artemis I Moon Mission
NASA conducted a hot fire Saturday of the core stage for the agency’s Space Launch System (SLS) rocket that will launch the Artemis I mission to the Moon. The hot fire is the final test of the Green Run series.
The test…
C Spire takes next step in grassroots campaign to get computer science in all public K-12 schools
Two Gulf Coast state lawmakers have introduced bills in the Mississippi Legislature advocated by C Spire and designed to get computer science curriculum in the classrooms of all the state’s 884 K-12 public and charter schools.
SB 2678 by State Senator Scott DeLano, R-Biloxi, and HB 633 by State House Representative Kevin Felsher, R-Biloxi, were introduced earlier this week and assigned to the Education Committee in each chamber. The bills, which would bring classroom instruction of computer science to all of the state’s 442,627 students, are expected to receive hearings soon.
The proposed laws come as the C Spire Foundation committed $1 million earlier this month to help school districts with teacher training and implementation. C Spire executives, education advocates, and technology leaders are optimistic the Legislature will consider and adopt new laws that will give elementary, middle, and high school students equal access to the computer science curriculum.
Last year, a grassroots effort to win legislative passage was cut short by the COVID-19 virus outbreak after a successful House of Representatives vote on a computer science bill in mid-March. The resulting global health pandemic closed most of Mississippi’s 884 public and charter K-12 schools and left many of the state’s 442,627…
The FDA granted the approval of Cabenuva and Vocabria to ViiV Healthcare
The U.S. Food and Drug Administration today approved Cabenuva (cabotegravir and rilpivirine, injectable formulation) as a complete regimen for the treatment of human immunodeficiency virus type 1 (HIV-1) infection in adults to replace a current antiretroviral regimen in those who are virologically suppressed on a stable antiretroviral regimen with no history of treatment failure and with no known or suspected resistance to either cabotegravir or rilpivirine. This is the first FDA-approved injectable, complete regimen for HIV-infected adults that is administered once a month.
The FDA also approved Vocabria (cabotegravir, tablet formulation), which should be taken in combination with oral rilpivirine (Edurant) for one month prior to starting treatment with Cabenuva to ensure the medications are well-tolerated before switching to the extended-release injectable formulation.
“Currently, the standard of care for patients with HIV includes patients taking daily pills to adequately manage their condition. This approval will allow some patients the option of receiving once-monthly injections in lieu of a daily oral treatment regimen,” said John Farley, M.D., M.P.H., director of the Office of Infectious Diseases in the FDA’s Center for Drug Evaluation and Research. “Having this treatment available for some patients provides an alternative for managing this chronic condition.”
The safety and efficacy…
Machine Learning for Predictive Maintenance – Top Opportunities for 2020-2021
Predictive Analytics in Retail – Why It Is Especially Important in 2020-21
Predictive analytics is a controversial technology when it comes to retail. On the one hand, knowing exactly what users will buy allows brands to sell more and more, reinforcing the mindless consumption trend. On the other hand, leveraging…
Lockheed Martin-Built Orion Spacecraft is Ready for its Moon Mission
NASA’s Orion spacecraft is ready for its mission to the Moon. Lockheed Martin has completed assembly and testing of the Orion Artemis I spacecraft and has transferred possession to NASA’s Exploration Ground Systems (EGS) team today. Assembled at Kennedy Space Center, the EGS team will then perform…
PA Hospital System Recruits College Students Home on Break in Fight Against COVID
St. Luke’s University Health Network (SLUHN) has tapped an unexpected, but welcome, labor pool of college students to help remotely monitor hospitalized COVID patients in eight of the Bethlehem-based network’s dozen hospitals using revolutionary medical technology.
Starting Dec. 19, a cadre of “virtual monitoring technicians” is now stationed 24/7 before…
Nutrition Experts Reveal Top Consumer Diet Changes Due to COVID-19
The global pandemic has changed all aspects of normal living, and ushered in an era where health and wellness are paramount decision drivers for the foreseeable future, especially when it comes to food and beverage choices. The 2021 Pollock Communications and Today’s Dietitian “What’s Trending in Nutrition” survey, with…
SARS-CoV-2 UK Variant Testing Now Available as Fee-For-Service and Complete PCR Kit for Testing Labs
GT Molecular, a rapidly expanding molecular diagnostics biotech, has launched two highly sensitive tests for the dangerous UK Variant of SARS-CoV-2 (B.1.1.7).
Nationwide Wastewater Testing Program
The fee-for-service testing of wastewater for the presence of SARS-CoV-2 and the variants in circulation provides communities with a rapid, highly cost-effective method to understand…
Northway Biotech is a leading contract development and manufacturing organization (CDMO) specializing in the development and manufacturing of biopharmaceuticals
By Tina Geiger / Staff WriterNorthway Biotech, a biopharmaceutical contract development and manufacturing organization (CDMO), established in 2004, with an EMA and FDA-compliant, state-of-the-art, cGMP manufacturing site in Europe, announced at the virtual grand opening ceremony on Jan. 20, 2021, the opening of its new 30,000-square-foot process development and cGMP manufacturing site in Waltham, Massachusetts.
From cell line development to cGMP DS manufacturing and aseptic filling, the state-of-the-art facility in the booming biotech hub in the Greater Boston area will provide end-to-end services for biologics microbial and mammalian based biologics. Currently, the new site has fully established process, analytical method development, and quality control labs supporting local and international customer projects since summer 2020. The cGMP biomanufacturing suite will house 500 L microbial and 2,000 L mammalian bioreactors and be operational in Q4 2021, representing a capital investment program worth $40 million.
“Northway Biotech reaches an important strategic milestone to further strengthen its leadership by opening a second biomanufacturing facility and its first in the United States. We are very excited about this expansion and are poised to support our next-door partners in the Boston biotech hub, as well as other domestically or internationally located companies, by enabling accelerated development and manufacturing of their novel, life-saving biopharmaceuticals for clinical or commercial needs,” said Dr. Vladas Algirdas Bumelis, CEO of Northway Biotech and Executive Chairman of the company’s Board of Directors and Advisory Board.
Earlier last month, the company announced that it is changing its brand name from Northway Biotechpharma to Northway Biotech to harmonize its brand name across…
MORE ARTICLES
Addiction, Substance Use and Recovery During the COVID-19 Pandemic
The Washington Health Alliance and Bree Collaborative Partner in Effort to Increase Value-Based Care
CES 2021: Mando Corporation Unveils New Vision of Autonomous Driving Technology
Mando explains the details of “Freedom” they define, especially in terms of freedom in mobility such as “Space Freedom,” “Smart Delivery,” etc. Also, a future automotive solution, where a vehicle seamlessly communicates with a driver via an integrated module of “x-by-Wire” technology including Mando’s BbW (Brake-by-Wire) and SbW (Steer-by-Wire)…
First Patient Enrolls in PRECISIONS Study for Treatment of Idiopathic Pulmonary Fibrosis
Today, the Pulmonary Fibrosis Foundation (PFF) announced enrollment of the first patient in PRECISIONS (Prospective tReatment EffiCacy in IPF uSIng genOtype for Nac Selection) clinical trial. This is the first clinical trial to apply the principles of precision medicine to the treatment of patients with…
VIVITROL Is Quickly Becoming the Go-To Treatment Option for Getting Rid of Opioid Addiction
Dr. Russell Surasky has been turning heads with his effective use of VIVITROL® for successfully treating opioid addiction. This monthly injection has been found to reduce addictive cravings for opiate drugs. Unlike other alternatives like Suboxone and Methadone, it is not an opiate itself.
The fact that VIVITROL is not…
In modern times, there has arguably never been a worse time to find yourself dealing with substance abuse addiction due to the impact of the COVID-19 pandemic.
Since the end of 2019, the world has been plunged into a sea of isolation, lockdowns, working from home, social distancing, and more.
Unfortunately, such conditions make it even harder for those dealing with substance abuse and recovery to deal with their problems effectively across the long-term.
During the pandemic, studies found that almost half of all Americans were experiencing negative effects on their mental health (Kaiser Family Foundation) – with there being strong links between substance abuse and mental wellbeing.
Studies from True Life Recovery and the U.S. Department of Health & Human Services and San Diego-based Millennium Health revealed that the pandemic had also led to a direct rise in alcohol and drug abuse.
In May 2020, a 55% rise in alcohol consumption across a 30-day period was announced, as well as a 36% increase in the use of marijuana and prescription opioids.
Across 75,000 different US urine samples, it was also found that people were 23% more likely to test positive for methamphetamine,…
EDITOR'S
CHOICE
The Washington Health Alliance and Bree Collaborative Partner in Effort to Increase Value-Based Care
NASA, FAA Partnership Bolsters American Commercial Space Activities
NASA and the Federal Aviation Administration (FAA) signed a new memorandum of understanding (MOU) reaffirming the agencies’ longstanding relationship to foster robust American commercial space transportation capabilities, including commercial crew and cargo activities.
The NASA-FAA MOU follows the success of NASA’s SpaceX Crew-1
Western North Carolina Emergency Field Hospital Accepts First Patient
Today, Samaritan’s Purse opened its 30-bed Emergency Field Hospital in Lenoir, North Carolina. The coronavirus pandemic has overwhelmed the region’s medical infrastructure, and hospitals are over capacity. The field hospital, specialized as a respiratory care unit, will help relieve the five local healthcare systems’ burden.
On…
CVS Health Provides Update on COVID-19 Vaccinations in Long-Term Care Facilities
CVS Health is now administering COVID-19 vaccines in skilled nursing facilities in 49 states, with the rollout beginning in 36 states and Washington, D.C. last week. Start dates were as follows:
- December 21: Connecticut, Florida, Kentucky, Maine, Nevada, New Hampshire, New York, Ohio, Oklahoma, Oregon, Vermont
- December 23: Maryland
…
